E
Elias Castanas
Researcher at University of Crete
Publications - 211
Citations - 10660
Elias Castanas is an academic researcher from University of Crete. The author has contributed to research in topics: Receptor & Cancer. The author has an hindex of 45, co-authored 206 publications receiving 9367 citations. Previous affiliations of Elias Castanas include Pierre-and-Marie-Curie University & National and Kapodistrian University of Athens.
Papers
More filters
Journal ArticleDOI
Enhanced OXER1 expression is indispensable for human cancer cell migration.
TL;DR: In this paper, the role of OXER1 and its endogenous ligand in the control of cell migration of human cancer epithelial cells (DU-145, T47D and Hep3B), mimicking the activation/migration phase of healing.
Journal ArticleDOI
Comparative thermodynamics of opioid receptor ligand interaction in the bovine adrenal medulla membranes—Evidence of opioid site heterogeneity
TL;DR: A marked dependence on temperature of agonist binding delta, mu and kappa 1-3 opioid sites in the bovine adrenal medulla was observed, suggesting the interaction of opioid agonists with their receptor is exergonic and entropy driven.
Journal ArticleDOI
Relation between glucose tolerance and serum insulin levels in man before and after thiopental intravenous administration.
TL;DR: A small but significant decrease in glucose tolerance, not related to serum insulin levels, was seen in healthy volunteers before and after a single dose of intravenous sodium thiopental.
Journal ArticleDOI
Original contributionAnti–saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease
Ioannis E. Koutroubakis,Efthymia Petinaki,Ioannis A. Mouzas,Ioannis G. Vlachonikolis,Evangelia Anagnostopoulou,Elias Castanas,Antonios N. Maniatis,Elias A. Kouroumalis +7 more
TL;DR: In this paper, perinuclear antineutrophil cytoplasmic autoantibodies (pANCA) and anti-Saccharomyces cerevisiae mannan antibodies (ASCA) were combined as a valuable diagnostic approach in inflammatory bowel disease (IBD).
Journal Article
[Characterization and modulation of anterior pituitary binding sites for rat corticotropin releasing factor (r-CRF)].
TL;DR: The finding suggests that circulating glucocorticoids may control the anterior pituitary binding sites for CRF, either by a direct action on the anteriorpituitary, or by a modulatory effect on hypothalamic CRF secretion.